Skip to main content
SpringerLink
Log in

Psychogene Schmerzen - Screening und indikationsgerechte Behandlung

Frühe psychische Exploration verhindert diagnostische Odyssee

  • Fortbildung
  • Published:
Schmerzmedizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Poloni N et al. Hospitalized Patients with Medically Unexplained Physical Symptoms: Clinical Context and Economic Costs of Healthcare Management. Behav Sci (Basel). 2019;9(7):80

  2. Bromet E et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90

  3. Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299-312

  4. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet. 2009;374(9690):609-19

  5. Fink P, Hansen MS, Oxhøj ML. The prevalence of somatoform disorders among internal medical inpatients. J Psychosom Res. 2004;56(4):413-8

  6. Kohlmann S, Gierk B, Hilbert A, Brähler E, Löwe B. The overlap of somatic, anxious and depressive syndromes: A population-based analysis. J Psychosom Res. 2016;90:51-56

  7. Husain M, Chalder T. Medically unexplained symptoms: assessment and management. Clin Med (Lond). 2021;21(1):13-18

  8. Zou W, Feng R, Yang Y. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression. PLoS One. 2018;13(6):e0197267

  9. Rief W, Barsky AJ. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology. 2005;30(10):996-1002

  10. Barsky AJ. Amplification, somatization, and the somatoform disorders. Psychosomatics. 1992;33(1):28-34

  11. Rief W, Broadbent E. Explaining medically unexplained symptoms-models and mechanisms. Clin Psychol Rev. 2007;27(7): 821-41

  12. Henningsen P. Management of somatic symptom disorder. Dialogues Clin Neurosci. 2018;20(1):23-31

  13. Pfeiffer M, Reiff J, Braus DG. Somatoforme Störungen und Diabetes. Der Diabetologe. 2021;17(7):733-8

  14. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288(5472):1765-9

  15. Mahabadi B et al. Diabetes und Depression. Der Diabetologe. 2021;17(7):727-32

  16. Linsmayer D, Neidlinger PK, Braus DF. [Rheumatism and the mind-A mini review]. Orthopade. 2019;48(11):957-62

  17. Borisovskaya A, Chmelik E, Karnik A. Exercise and Chronic Pain. Adv Exp Med Biol. 2020;1228:233-53

  18. Linsmayer D, Neidlinger PK, Braus DF. Rheuma und Psyche - Eine Kurzübersicht. Der Orthopäde. 2019;48(11):957-62

  19. Malhi GS et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary. Bipolar Disord. 2020;22(8):788-804

  20. Fallon BA. Pharmacotherapy of somatoform disorders. J Psychosom Res. 2004;56(4): 455-60

  21. Bushnell GA et al. Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014. JAMA Psychiatry. 2017;74(7):747-55

  22. Qato DM, Ozenberger K, Olfson M. Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA. 2018;319(22):2289-98

  23. Martin A et al. A one-session treatment for patients suffering from medically unexplained symptoms in primary care: a randomized clinical trial. Psychosomatics. 2007;48(4):294-303

  24. Bair MJ et al. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433-45

Download references

Author information

Authors and Affiliations

  1. Vitos Rheingau, Kloster-Eberbach-Str. 4, 65346, Eltville, Germany

    Denise Linsmayer

  2. Direktor Vitos Rheingau, Kloster-Eberbach-Str. 4, 65346, Eltville, Germany

    Dieter F. Braus

Authors
  1. Denise Linsmayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dieter F. Braus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Denise Linsmayer.

Ethics declarations

Denise Linsmayer gibt an, dass kein Interessenskonflikt besteht. Dieser Beitrag enthält keine Studien an Menschen oder Tieren. Dieter F. Braus erklärt, dass er sich bei der Erstellung des Beitrages nicht von wirtschaftlichen Interessen leiten ließ. Er legt die folgenden potenziellen Interessenkonflikte offen: Produktneutrale Vortragstätigkeit über Verträge für Lilly Deutschland, GSK, Janssen-Cilag, Lundbeck, Pfizer, Takeda, Medice, Servier, MSD, Idorsia, Boehringer-Ingelheim, med update, streamedup.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Linsmayer, D., Braus, D. Psychogene Schmerzen - Screening und indikationsgerechte Behandlung. Schmerzmed. 40, 33–37 (2024). https://doi.org/10.1007/s00940-023-4654-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00940-023-4654-7

Search

Navigation